Clinical Trials Logo

Asthma, Aspirin-Induced clinical trials

View clinical trials related to Asthma, Aspirin-Induced.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03028350 Active, not recruiting - Clinical trials for Asthma, Aspirin-Induced

Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)

Start date: July 17, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this phase 2 study is to assess the safety and efficacy of oral ifetroban for the treatment of aspirin-exacerbated respiratory disease (AERD). AERD is a disease that involves asthma, recurring nasal polyps, and respiratory reactions to aspirin and other nonsteroidal anti-inflammatory drugs.